Glenn Mills

4.7k total citations · 1 hit paper
119 papers, 3.4k citations indexed

About

Glenn Mills is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Glenn Mills has authored 119 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Glenn Mills's work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (17 papers) and Head and Neck Cancer Studies (15 papers). Glenn Mills is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (17 papers) and Head and Neck Cancer Studies (15 papers). Glenn Mills collaborates with scholars based in United States, Canada and Australia. Glenn Mills's co-authors include Runhua Shi, Syed Hasan Raza Jafri, Tannaz Armaghany, Jon D. Wilson, F. Yunus, R. Bell, Erhard Quebe‐Fehling, J.J. Body, Pierre Major and Ehtesham Abdi and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Glenn Mills

113 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials

2001 520 citations Glenn Mills et al. profile →

Peers

Countries citing papers authored by Glenn Mills

Since Specialization

Citations

This map shows the geographic impact of Glenn Mills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Mills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Mills more than expected).

Fields of papers citing papers by Glenn Mills

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Mills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Mills. The network helps show where Glenn Mills may publish in the future.

Co-authorship network of co-authors of Glenn Mills

This figure shows the co-authorship network connecting the top 25 collaborators of Glenn Mills. A scholar is included among the top collaborators of Glenn Mills based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glenn Mills. Glenn Mills is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Propensity Score Matching Analysis of the Effect of Payer Status on the Survival of Colon Cancer Patients 2021 ·Cureus ·(unknown), (unknown), (unknown), Glenn Mills, Sarah P. Thayer, Runhua Shi	1
2	Comparing cell‐free circulating tumorDNAmutational profiles of disease‐free and nonresponders patients with oropharyngeal squamous cell carcinoma 2020 ·Laryngoscope Investigative Otolaryngology ·Alok R. Khandelwal, (unknown), (unknown), (unknown), (unknown), Tara Moore‐Medlin, Glenn Mills, José M. Flores, Hong Yin, Cherie‐Ann O. Nathan	16
3	Plasmablastic Lymphoma, a Rare Entity in Bone Marrow with Unusual Immunophenotype and Challenging Differential Diagnosis 2019 ·SHILAP Revista de lepidopterología ·(unknown), Rodney E. Shackelford, Samip Master, Glenn Mills, (unknown), (unknown), Eric X. Wei	7
4	A Qualitative Study Exploring Barriers and Facilitators of Enrolling Underrepresented Populations in Clinical Trials and Biobanking 2019 ·Frontiers in Cell and Developmental Biology ·Terry C. Davis, Connie L. Arnold, Glenn Mills, Lucio Miele	79
5	Adenoma Prevalence in Blacks and Whites Having Equal Adherence To Screening Colonoscopy: The National Colonoscopy Study 2017 ·Clinical Gastroenterology and Hepatology ·Robin B. Mendelsohn, Sidney J. Winawer, (unknown), Glenn Mills, Paul Jordan, Michael J. O’Brien, (unknown), (unknown), Timothy R. Church, Margaret T. Mandelson, John I. Allen, Andrew Feld, Noah D. Kauff, (unknown), (unknown), (unknown), (unknown), Sara Fischer, Deborah Kuk, Ann G. Zauber	4
6	Successful Treatment of Richter Transformation with Ibrutinib in a Patient with Chronic Lymphocytic Leukemia following Allogeneic Hematopoietic Stem Cell Transplant 2017 ·Case Reports in Oncology ·Samip Master, (unknown), Amol Takalkar, (unknown), Richard Mansour, Glenn Mills, (unknown)	8
7	Insurance Status and Other Non-biological Factors Predict Outcomes in Acute Myelogenous Leukemia: Analysis of Data from the National Cancer Database 2016 ·Anticancer Research ·Samip Master, Reinhold Munker, Zhenzhen Shi, Glenn Mills, Runhua Shi	28
8	Immune checkpoint inhibitors: the new frontier in non–small cell lung cancer treatment 2016 ·OncoTargets and Therapy ·Hazem El‐Osta, (unknown), Glenn Mills, Prakash Peddi	24
9	The Shreveport Myeloma Experience: Survival, Risk Factors and Other Malignancies in the Age of Stem Cell Transplantation 2015 ·Acta Haematologica ·Reinhold Munker, Runhua Shi, (unknown), Srinivas Devarakonda, James D. Cotelingam, Jerry McLarty, Glenn Mills, Jonathan Glass	5
10	Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: results of the WFU CCOP Research Base Protocol 97106 2015 ·The Journal of Community and Supportive Oncology ·Kathryn M. Greven, L. Douglas Case, Lawrence R. Nycum, Patricia J. Zekan, David D. Hurd, Ernie Balcueva, Glenn Mills, Robin Zoň, Patrick J. Flynn, (unknown), Edward Shaw, Glenn J. Lesser, Michelle J. Naughton	4
11	Factors associated with genital human papillomavirus infection among adult females in the United States, NHANES 2007–2010 2014 ·BMC Research Notes ·Runhua Shi, Srinivas Devarakonda, Lihong Liu, Hannah Taylor, Glenn Mills	33
12	Pharmacodynamic evaluation of temsirolimus in patients with newly diagnosed advanced‐stage head and neck squamous cell carcinoma 2010 ·Head & Neck ·Oleksandr Ekshyyan, Glenn Mills, Timothy Lian, (unknown), Xiaohua Rong, Mary Lowery‐Nordberg, Fleurette Abreo, Diana M. Veillon, Gloria Caldito, Lisa A. Speicher, Jonathan Glass, Cherie‐Ann O. Nathan	25
13	Antiandrogen withdrawal in castrate‐refractory prostate cancer 2008 ·Cancer ·Oliver Sartor, Catherine M. Tangen, Maha Hussain, Mario A. Eisenberger, (unknown), Joseph A. Fontana, Robert Chapman, Glenn Mills, Derek Raghavan, E. David Crawford	116
14	Adenoma Recurrences After Resection of Colorectal Carcinoma: Results From the Southwest Oncology Group 9041 Calcium Chemoprevention Pilot Study 2003 ·Annals of Surgical Oncology ·David Z. J. Chu, Kari Chansky, David S. Alberts, Frank L. Meyskens, Cecilia M. Fenoglio‐Preiser, Saul E. Rivkin, Glenn Mills, Jeffrey K. Giguere, Gary E. Goodman, James L. Abbruzzese, Scott M. Lippman	13
15	The Role of Intratumoral Therapy With Cisplatin/Epinephrine Injectable Gel in the Management of Advanced Squamous Cell Carcinoma of the Head and Neck 2002 ·Archives of Otolaryngology - Head and Neck Surgery ·Barry L. Wenig, Jochen A. Werner, Dan J. Castro, Kasi S. Sridhar, Harinder S. Garewal, W. Kehrl, A Płużańska, (unknown), Peter D. Costantino, Glenn Mills, Frank Dunphy, Elaine K. Orenberg, Richard D. Leavitt	30
16	Radical combined treatment of locally extensive head and neck cancer in the elderly 2001 ·American Journal of Otolaryngology ·Federico L. Ampil, Glenn Mills, Fred J. Stucker, Gary V. Burton, Cherie‐Ann O. Nathan	12
17	Intratumoral focused chemotherapy with cisplatin/ epinephrine injectable gel for palliative treatment of metastatic breast cancer 1998 ·European Journal of Cancer ·Indrajit Fernando, Peter D. Eisenberg, (unknown), Janine Mansi, Glenn Mills, Elisabeth G.E. de Vries	1
18	Solitary Plasmacytoma of the Sacrum Presenting as a Pelvic Mass 1995 ·Southern Medical Journal ·(unknown), Glenn Mills, (unknown), Fleurette Abreo	3
19	Eccrine poroma 1989 ·Journal of the American Podiatric Medical Association ·H Lemont, Glenn Mills	2
20	Predictive Value of Trypan Blue Exclusion Viability Measurements for Colony Formation in a Human Tumor Cloning Assay 1984 ·PubMed ·John D. Cowan, Daniel D. Von Hoff, (unknown), Glenn Mills, Gary M. Clark	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact